Trial Profile
Safety of abatacept versus TNF inhibitors patients with juvenile idiopathic arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Nov 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Adverse reactions
- 11 Nov 2016 New trial record